Epilepsy Center, Cleveland Clinic, Cleveland, OH, USA.
Epilepsy Center, Cleveland Clinic, Cleveland, OH, USA.
Lancet Neurol. 2015 Mar;14(3):283-90. doi: 10.1016/S1474-4422(14)70325-4. Epub 2015 Jan 29.
Half of patients who have resective brain surgery for drug-resistant epilepsy have recurrent postoperative seizures. Although several single predictors of seizure outcome have been identified, no validated method incorporates a patient's complex clinical characteristics into an instrument to predict an individual's post-surgery seizure outcome.
We developed nomograms to predict complete freedom from seizures and Engel score of 1 (eventual freedom from seizures allowing for some initial postoperative seizures, or seizures occurring only with physiological stress such as drug withdrawal) at 2 years and 5 years after surgery on the basis of sex, seizure frequency, secondary seizure generalisation, type of surgery, pathological cause, age at epilepsy onset, age at surgery, epilepsy duration at time of surgery, and surgical side. We designed the models from a development cohort of patients who had resective surgery at the Cleveland Clinic (Cleveland, OH, USA) between 1996 and 2011. We then tested the nomograms in an external validation cohort operated on over a similar period in four epilepsy surgery centres, in Brazil, France, Italy, and the USA. We assessed performance of the nomogram by calculating concordance statistics and assessing the calibration of predicted freedom from seizures with the reported freedom from seizures and Engel score of 1.
The development cohort included 846 patients and the validation cohort included 604 patients. Variables included in the nomograms were sex, seizure frequency, secondary seizure generalisation, type of surgery, and pathological cause. In the development cohort, the baseline risk of complete freedom from seizures was 0·57 at 2 years and 0·40 at 5 years. The baseline risk of Engel score of 1 was 0·69 at 2 years and 0·62 at 5 years. In the validation cohort, the models had a concordance statistic of 0·60 for complete freedom from seizures and 0·61 for Engel score of 1. Calibration curves showed adequate calibration (judged by eye) of predicted and reported freedom from seizures, throughout the range of seizure outcomes.
If validated in prospective cohorts, these nomograms could be used to predict seizure outcomes in patients who have been judged eligible for epilepsy surgery.
Cleveland Clinic Epilepsy Center.
接受手术切除治疗耐药性癫痫的患者中,有一半会出现术后复发癫痫。尽管已经确定了一些术后癫痫发作的单一预测因子,但尚无经过验证的方法将患者的复杂临床特征纳入预测个体术后癫痫发作结果的工具中。
我们基于性别、发作频率、继发性发作泛化、手术类型、病理原因、癫痫起始年龄、手术年龄、手术时癫痫持续时间和手术侧,制定了预测术后 2 年和 5 年完全无癫痫发作和 Engel 评分 1 分(最终无癫痫发作,但允许术后初期有一些发作,或仅在生理应激下如停药时出现发作)的列线图。我们从 1996 年至 2011 年在美国克利夫兰诊所接受手术的患者中建立了该模型的开发队列。然后,我们在巴西、法国、意大利和美国的四个癫痫手术中心进行了相似时间段的手术患者的外部验证队列中测试了该列线图。我们通过计算一致性统计量并评估报告的无癫痫发作和 Engel 评分 1 分的预测值来评估列线图的性能。
开发队列包括 846 例患者,验证队列包括 604 例患者。纳入列线图的变量包括性别、发作频率、继发性发作泛化、手术类型和病理原因。在开发队列中,术后 2 年完全无癫痫发作的基线风险为 0.57,术后 5 年为 0.40。术后 2 年 Engel 评分 1 的基线风险为 0.69,术后 5 年为 0.62。在验证队列中,模型对于完全无癫痫发作的一致性统计量为 0.60,对于 Engel 评分 1 的一致性统计量为 0.61。校准曲线显示,在整个癫痫发作结局范围内,预测和报告的无癫痫发作具有适当的校准(通过肉眼判断)。
如果在前瞻性队列中得到验证,这些列线图可用于预测已被判断为适合癫痫手术的患者的癫痫发作结果。
克利夫兰诊所癫痫中心。